Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Roche discloses metabotropic glutamate mGlu4 receptor PAMs

March 8, 2019

Decreased inhibition, but no hyperexcitation, in multiple autism models

March 8, 2019

Three pivotal studies of rapastinel in adjunctive treatment of MDD miss primary endpoint

March 7, 2019

Glycopeptide derivative of angiotensin-(1-7) reverses cognitive dysfunction in mice models of VCID

March 7, 2019

Chinese researchers patent 5-HT1A receptor agonists

March 7, 2019

VU-6012962 results in decreased anxiety response in preclinical models

March 7, 2019

High-throughput, low-stress analysis method separates out brain cells

March 7, 2019

Marinus initiating pivotal phase III study of oral ganaxolone in pediatric PCDH19-related epilepsy

March 6, 2019

FDA approves Spravato for treatment-resistant depression

March 6, 2019

Denali Therapeutics identifies EIF2B activators

March 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...